BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Mirum Pharmaceuticals
MIRM
$6.14B
| $4.44M | ﹤0.01% |
181,169
+146,114
| +417% | +$1.56M |
|
|
YARW
3527
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $4.44M | ﹤0.01% |
266
+3
| +1% | +$50K |
|
3528
Shinhan Financial Group
SHG
$35.6B
| $4.41M | ﹤0.01% |
115,944
-141,833
| -55% | -$5.25M |
|
|
VNTR
3529
DELISTED
Venator Materials PLC
VNTR
| $4.41M | ﹤0.01% |
1,152,319
-139,691
| -11% | -$454K |
|
3530
Smart Sand
SND
$194M
| $4.4M | ﹤0.01% |
1,745,534
+55,729
| +3% | +$138K |
|
3531
Cyclerion Therapeutics
CYCN
$16.7M
| $4.4M | ﹤0.01% |
80,834
+5,361
| +7% | +$501K |
|
3532
Nature's Sunshine
NATR
$288M
| $4.38M | ﹤0.01% |
490,230
+622
| +0.1% | +$5.84K |
|
3533
BlackRock TCP Capital
TCPC
$345M
| $4.38M | ﹤0.01% |
311,412
-4,608
| -1% | -$64.3K |
|
3534
Concrete Pumping Holdings
BBCP
$491M
| $4.37M | ﹤0.01% |
798,490
+145,607
| +22% | +$593K |
|
3535
National Grid
NGG
$81.3B
| $4.31M | ﹤0.01% |
77,698
+77,594
| +74,610% | +$3.99M |
|
|
CHK.PRD
3536
DELISTED
Chesapeake Energy Corp. 4.5% Cum. Cnvrtbl. Prfrd. Stock
CHK.PRD
| $4.25M | ﹤0.01% |
207,514
+20,401
| +11% | +$582K |
|
3537
CGI
GIB
$15.5B
| $4.21M | ﹤0.01% |
50,277
+184
| +0.4% | +$14.8K |
|
|
AXAS
3538
DELISTED
Abraxas Petroleum Corp
AXAS
| $4.2M | ﹤0.01% |
597,691
+2,046
| +0.3% | +$13.2K |
|
3539
Kura Sushi USA
KRUS
$593M
| $4.19M | ﹤0.01% |
164,667
+2,755
| +2% | +$60.8K |
|
|
SBBP
3540
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.15M | ﹤0.01% |
1,984,117
-530,480
| -21% | -$1.02M |
|
3541
SLR Investment Corp
SLRC
$715M
| $4.14M | ﹤0.01% |
201,026
+6,616
| +3% | +$136K |
|
3542
Korea Electric Power
KEP
$16B
| $4.12M | ﹤0.01% |
348,596
-20,613
| -6% | -$237K |
|
|
LGF.A
3543
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $4.12M | ﹤0.01% |
386,000
+65,500
| +20% | +$603K |
|
|
MFGP
3544
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $4.11M | ﹤0.01% |
293,064
-11,181
| -4% | -$155K |
|
3545
Genasys
GNSS
$79.2M
| $4.08M | ﹤0.01% |
1,248,919
-5,564
| -0.4% | -$18.8K |
|
3546
PUT
Boeing
BA
$185B
| $4.07M | ﹤0.01% |
+12,500
| New | +$4.43M |
|
3547
Rimini Street
RMNI
$471M
| $4.07M | ﹤0.01% |
1,048,162
+26,436
| +3% | +$106K |
|
3548
Qfin Holdings
QFIN
$1.61B
| $4.03M | ﹤0.01% |
412,484
+351,780
| +580% | +$3.18M |
|
|
IEFN
3549
DELISTED
iShares Evolved U.S. Financials ETF
IEFN
| $3.97M | ﹤0.01% |
150,000
| – | – |
|
3550
Neuronetics
STIM
$166M
| $3.93M | ﹤0.01% |
875,804
-138,033
| -14% | -$858K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.